SubjectWell, an engagement platform for matching patients with chronic health conditions to new care options, announced a $35 million Series B funding round led by Asset Management Ventures, with participation from all existing investors, and joined by Bertelsmann. This new investment will accelerate the growth of SubjectWell’s existing clinical trial patient recruitment efforts, expand its support of cancer research, and fund production of its awareness initiatives for post-approval treatments. Read more.
Related Posts
Calibrate Raises $100M for Obesity-Focused Telehealth: Report
Founders Fund and Tiger Global led the round and were joined by investors including Optum Ventures, Forerunner Ventures, Threshold Ventures, and Redesign Health.
August 26, 2021
Peppy, a British B2B Health Platform, Raises £6.6M in Series A Funding Led by Felix Capital
Previous investors including Outward VC, Seedcamp, and Hambro Perks, also participated.
July 27, 2021
Startup Bold Nabs $17M to Scale Up ‘Movement-as-Medicine’ Program
Bold's series A funding was led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The startup has raised $27 million to date.
September 18, 2023
Memora Health Brings in $40M to Grow Platform
Transformation Capital led the financing
February 15, 2022